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Abstract 
Background: The UK’s NHS intends to move from the current Read code system to the 
international, detailed Systematized Nomenclature of Medicine Clinical Terms 
(SNOMED-CT) to facilitate more clinically appropriate coding of conditions and 
associated risk factors and outcomes.  Given concerns about coding behaviour of 
General Practitioners, we sought to study current coding patterns in allergies and 
identify lessons for the future migration to SNOMED-CT. 
Methods: Data from 2,014,551 primary-care consultations in over 100,000 patients 
with one or more of 11 potentially allergic diseases (anaphylaxis, angioedema, asthma, 
conjunctivitis, drug allergies, eczema, food allergy, rhinitis, urticaria, venom allergy and 
other probable allergic disorders) from the Scottish Primary Care Clinical Informatics 
Unit Research (PCCIU-R) database were descriptively analysed and visualised to 
understand Read code usage patterns. 
Results: We identified 352 Read codes for these allergic diseases, but only 36 codes 
(10%) were used in 95% of consultations; 73 codes (21%) were never used.  Half of all 
usage was for Quality and Outcomes Framework codes for asthma.  Despite 149 
detailed codes (42%) being available for allergic triggers, these were infrequently used.  
Conclusions:  This analysis of Read codes use suggests that, introduction of the more 
detailed SNOMED-CT, in isolation, will not improve the quality of allergy coding in 
Scottish primary care. The introduction of SNOMED-CT should be accompanied by 
initiatives aimed at improving coding quality, such as the definition of terms/codes, 
availability of terminology browsers, a recommended list of codes and mechanisms to 
incentivize detailed coding of the condition and the underlying allergic trigger.   
Keywords: allergy, coding, primary care, Read codes, SNOMED-CT 
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Background  
The UK’s National Health Services currently use two clinical coding systems: the 
International Classification of Disease (ICD-10) in hospitals and Read codes in primary 
care.  This parallel use of two different coding systems  has historic origins, but results 
in major challenges to developing a comprehensive electronic picture of overall care 
provision.(1)  Moreover, due to limited detail – particularly in ICD-10 – these coding 
systems have major gaps.(2)   
 
Given these parallel coding systems and the accompanying coding gaps (which are also 
present in other disease areas), in 2011 the UK’s Standardisation Committee for Care 
Information officially approved the Systematized Nomenclature of Medicine Clinical 
Terms (SNOMED-CT) as a “fundamental standard” for the UK, to become the sole 
supported terminology across primary and secondary care.(3) This move is potentially 
welcome, but we cannot assume that this action alone will translate into improved 
coding quality.(4)  Also, the wide range of allergic disorders, the fact that these occur 
across the life course, the frequent comorbidities, and that a number of organ systems 
can be affected, makes the task of clinical coding in allergy very complex.(5, 6)  There 
is additionally a need to code for the underlying allergenic trigger and any related 
factors.(7-9) Consideration of extensive differential diagnoses, example 
gastroesophageal reflux, structural abnormalities of the upper and lower airways, 
aspiration of a foreign body etc, in clinical practice has also been emphasized by the 
allergy community.(10)   
 
We sought to describe the allergy codes currently available in primary care and their 
structures, and then quantify the actual patterns of use of these codes by a large 
group of general practitioners (GPs) with a view to deriving lessons that should help 
maximize the benefits of the impending national move to SNOMED-CT and minimise 
current complexity. 
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Methods  
Identification of allergy codes available in the Read coding system 
We used the NHS Clinical Terminology Browser, version-one, to identify Read 
codedescriptions relevant to any of the following allergic disorders: anaphylaxis, 
angioedema, asthma, conjunctivitis, drug allergies, eczema, food allergy, rhinitis, 
urticaria, venom allergy and other potential allergic disorders. The retrieved codes 
were categorized into allergic or not-allergic using the following criteria: i) since Read 
codes have a mono-axial hierarchy,(11) all child codes (with more details) listed under 
a parent allergy code were included, even if these were unlikely to have an allergic 
basis (e.g. the parent allergy code ‘M11.’-‘atopic dermatitis and related’ and it’s child 
code under ‘M110.’-‘napkin dermatitis’;  ii) conditions commonly seen, investigated or 
managed by UK allergists, whether IgE-mediated or not, were considered eligible. For 
example, although most cases of chronic urticaria do not have an underlying IgE-
mediated basis, this condition is commonly managed by allergists, so we extracted 
data on urticaria related codes; and iii) when the parent code did not refer to allergic 
problems, but a child code referred to an allergy, the child code was categorized as 
allergy (e.g. parent code ‘F4C0.’-‘acute conjunctivitis’ for child code ‘F4C06’-‘acute 
atopic conjunctivitis’). We excluded ‘Family history (FH) of asthma’ and ‘FH: eczema’ 
from categorizing as allergy codes because these did not relate to the person 
themselves. Two reviewers independently selected the allergy codes; disagreements 
were resolved by discussion. Cohen’s Kappa, calculated using SPSS version-19, showed 
an interrater reliability of 0.94 (95% CI 0.90-0.97), implying very good agreement. 
Structure and classification of codes  
Each of these codes were further independently classified using the Read code 
structure into: i) the type of concept coded; ii) causal allergen; and iii) the level of 
coding.   
Type of concept coded referred to whether the code was used to label a diagnosis, 
cause of illness, a symptom, family history, history, management, observation, 
assessment, a test, test-result or for another purpose.  
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Causal allergens were used to categorize the codes into: food, drugs, animal, bird, fish, 
insect, plant, microbe, chemical, atmospheric, other specific, non-specific and not-
applicable. Causal allergen was “not-applicable” when the codes were for observation 
or management purposes (example ‘66G7.-allergic disorder treatment stopped’, 
‘66G8.-carries adrenaline preloaded injection pen’, ‘6636. -inhaler technique shown’). 
“Non-specific” causal allergen was assigned to codes for descriptions where the causal 
allergen was not specified, such as ‘3359.-allergy skin test positive’ or ‘663N2-asthma 
disturbs sleep frequently’. “Other-specific” was applied to codes where the causal 
allergen was broadly specified, such as ‘1784.-asthma trigger - emotion’ or ‘M286.-
contact urticaria’. 
Level of detail Read codes follow a tree structure where parent codes could have three 
to one dots and the more specific child codes could have two to no dots. This allowed 
us to determine the level of detail (or granularity) by inspecting the number of dots 
available after the codes. Codes with no dots indicated that there were no further 
associated branch codes.  Codes with two dots were classified as ‘less detailed’ (e.g. 
‘H33..-asthma’), with one dot as ‘medium detailed’ (e.g.  ‘H330.-extrinsic (atopic) 
asthma’) and with no dot as ‘more detailed’ (e.g. ‘H3301-extrinsic asthma with status 
asthmaticus’).  
Once this process was complete, the usage of each allergy code and the category of 
codes was determined (see below). 
Usage of allergy codes 
Read code usage was evaluated through interrogating the Primary Care Clinical 
Informatics Unit-Research (PCCIU-R) database, from 2003-04 to 2009-10.(12) PCCIU-R 
is a nationally representative database for Scotland.(13) Data were available from 393 
GP practices between 2003-04 and 2006-07, 369 GP practices in 2007-08, 297 in 2008-
09 and 239 in 2009-10. The number of patients whose consultations included our list 
of allergy Read codes were 143,282, 185,848, 189,895, 186,996, 150,885, 127,467 and 
108,323 for -the respective individual years. Since more than one code could have 
been used in one GP consultation, we refer to usage as the number of times codes 
were used. Screen shots of Read terms available in drop down list, when searched by a 
keyword in a GP practice, is presented in Figure 1. The main exception to this is the 
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recording of drug allergies for which a separate electronic health record template 
exists. 
Usage of asthma codes pre- and post-QOF implementation 
Since the Scottish Quality and Outcomes Framework (QOF) for asthma (and a range of 
non-allergic disorders) came into force in 2004-05,(14) a comparison of codes for 
asthma usage was made between the pre and post-QOF periods. 
Ethics and permissions 
We received the data in three separate yearly tables: count of use of allergy codes, 
number of GP practices and number of patients. The governance of PCCIU-R database 
is covered by their Steering Group committee, who agreed to supply the data in 
accordance with their standard operating procedures (SOPs). Specific ethics 
committee approval was not required because PCCIU-R had already obtained blanket 
ethics permission for studies following their SOPs. We received aggregated data and 
no further information was sought or linked to these.  
 
Results  
Identification of allergy codes available in the Read coding system and their usage 
We identified 650 potentially relevant Read codes, of which 352 (54%) were identified 
as being eligible allergy codes using the criteria and methods above. Of these 352 
allergy codes, the biggest disease category coded was for asthma (34% of the total 
number), followed by “other” (29%), drug allergy (17%), urticaria (5%), food allergy 
(4%), eczema (3%), anaphylaxis (3%), rhinitis (3%), angioedema (1%), conjunctivitis 
(1%) and venom allergy (0.3%) (Supplementary web-Table 1). 
These codes were used a total of 2,311,843 times over the seven year study period. A 
cumulative frequency distribution of code usage (Figure 2) shows that 80% of code 
usage by GPs was associated with only 11 codes (3% of the total number of codes) and 
95% usage with 36 codes (10% of the total available codes). In Table 1, the eight 
greyed codes in the list of most frequently used codes indicate that the QOF asthma 
codes contributed to 50% of the usage. Usage rates for individual allergy codes varied 
dramatically: 73 codes (21% of the total) were never used (Table 2), but one code 
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(0.3% of all codes) 663H (‘Inhaler technique – good’) accounted for 22%, or nearly one-
quarter of all allergy code usage. The two other highly used codes were 663O (‘Asthma 
not disturbing sleep’) and 663Q (‘Asthma not limiting activities’), with 16% of the total 
usage each; these three codes (1% of all codes) together accounted for 54%, or over 
half of all usage of allergy codes by Scottish GPs. The remaining 248 codes (71%) 
contributed to only 5% of the code usage. 
Structure and classification of codes and usage rates for each of these 
Our analysis showed a significant mismatch between the numbers of codes available 
for different clinical concepts and the frequency with which GPs used these.  
Type of concept coded: Although diagnostic codes comprised the majority (47%) of 
eligible codes, these were used only 21% of the time. While observation codes 
comprised 15% of codes, these were used the most: 65% of the time. For angioedema, 
conjunctivitis, rhinitis, urticaria and venom allergy only diagnosis codes existed. The 
remaining codes encoded concepts related to the history (18%), management (5%), 
tests (5%), causes of illness (4%), assessment (3%), test-results (2%) or other concepts 
(1%). No symptom codes were identified among the 352 allergy codes. In an analysis 
to explore the type of code most frequently used for each allergic disorder, we found 
that observation codes were mostly used in relation to asthma and diagnosis codes 
were mostly used in relation to drug allergy, eczema and food allergy (Figure 3).  
Causal allergen: A drug was the causal allergen in 17.6% of the 352 codes. Specific 
causal allergens only applied to a small proportion of codes: food (4.8%), atmospheric 
(1.7%), animal (1.4%), bird (1.1%), insect (0.6%), microbe (0.3%), chemical (0.3%) and 
fish (0.3%). It was not-applicable in 18.8% codes. In half of the codes, causal allergens 
were non-specific (42%) or other-specific (7.7%).  
The most frequently used allergen codes were non-specific (64%), example ‘14F1.’-
‘history of eczema’, followed by non-applicable causal allergen codes (30%), example 
‘13Y4.’-‘asthma society member’. Codes with drug and food as causal allergen were 
used 5% and 1% times, respectively. Non-specific causal allergen codes alone were 
used for angioedema, conjunctivitis and eczema, followed by urticaria (97%), 
anaphylaxis (83%), other (80%), rhinitis (71%) and asthma (65%).   
Level of detail: Most of the codes available were medium detailed (n=191; 54%), then 
more detailed (n=149; 42%), thus leaving only 12 (3%) less detailed codes. The 
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availability of medium detailed codes was high in eczema (73%), asthma (68%), drug 
allergies (58%) and urticaria (56%), and was the only type of code for venom allergy 
(n=1).  More detailed codes were available in conjunctivitis (100%), followed by food 
allergy (85%), angioedema (75%) and anaphylaxis (63%). Of the 12 less detailed codes, 
four were for asthma (178..-‘asthma trigger’, 1O2..-‘asthma confirmed’, 663..-‘asthma 
monitoring’, H33..-‘asthma’), and one each was for drug allergy (14L..-‘history of drug 
allergy’), rhinitis (H17..-‘allergic rhinitis’) and urticaria (M28..-‘urticaria’) and five for 
other (14M..-‘history of non-drug allergy’, 335..-‘allergy skin test’, 66G..-‘allergic 
disorder monitoring’, H35..-‘extrinsic allergic alveolitis’, M11..-‘atopic dermatitis and 
related’).  
Turning to usage rates, medium detailed codes were the most frequently used (81%) 
and more detailed codes were used less (8%). More detailed codes were never used 
(n=42) despite their availability in: angioedema-67%, rhinitis-50%, other-44%, 
urticaria-43%, food allergy-27%, asthma-21%, and anaphylaxis-14%. In contrast, all the 
more detailed codes were used in conjunctivitis, drug allergy and eczema. 
Usage of asthma codes pre-QOF and post-QOF implementation 
Compared to 2003-04, when QOF was implemented in 2004-05,  usage of asthma 
codes pertaining to allergy remained the same at 118 codes per 100 consultations in 
both years,  (p>0.05, Chi-square=21), till 2006-07 and then gradually decreased to 116, 
115 and 114 codes/100 consultations in the subsequent years .  Usage of codes was 
highest for asthma among other disease areas (86% of total usage), of which use of 
less detailed codes beginning with H33 was 12%. The less detailed “H33..” code was 
used 5% times and the more detailed child codes were used 56% of times. 
 
Discussion  
We have found that there are hundreds of Read codes available to record allergic 
problems, but that these are poorly conceptualised, so that, for example, some codes 
which appear under a parent allergy code are unlikely to have an IgE-mediated basis 
and/or represent conditions which are managed by an allergist. We also found that 
there is a mismatch between the availability and usage of codes by GPs – in particular, 
10% (n=36) of codes were used 95% times and 21% (n=73) were never used.     
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Study strengths and limitations  
This study builds on over a decade of working with Read codes and our previous work 
on SNOMED-CT.(15) It is the first national investigation of primary care use of Read 
codes for allergic disorders. It is also based on a thorough analysis of the usage of Read 
codes for coding common allergic conditions using the GP records of over three million 
consultations over a seven year period.  
However, a key limitation is that the findings are based only on Read allergy codes 
from participating PCCIU-R GP practices in Scotland. While Read codes are used 
universally in UK primary care and in some other settings, this dataset might not 
reflect coding trends in other parts of UK or for non-allergic diseases. While the 
dataset bridges the introduction of QOF, the data may not reflect any recent 
improvement in coding behaviour and pre-QOF data were available for only one year. 
Thus, adequate comparison could not be made for pre-and post-QOF, since GPs may 
have already increased their usage of QOF codes in anticipation of the following year. 
Also, no attempt was made in this study to extract information from free-text, since it 
was based only on usage of Read codes. However, we do not believe that this is a 
significant limitation, since a systematic review found that morbidity coding in 
consultations is 66-99% complete..(16) Furthermore, a large study on over 2 million 
patients with allergies found that almost 94% of allergen information was recorded 
using coded data.(17) 
Interpretation in the light of the literature  
Our finding that GPs had frequently coded the reason for consultation (eight QOF 
asthma codes (Table 1) used 50% times) is a similar finding to coding in 
depression.(18) In contrast to the findings of a study on coding diabetes in primary 
care,(19) we showed that use of less detailed asthma codes was low. 
Implications for policy, practice and research  
Understanding triggers, avoiding allergens and treating symptoms are key to managing 
allergic conditions.(6, 20) The National Allergy Strategy Group advocates that there 
needs to be greater awareness and understanding of allergy in primary care to allow 
more patients to be managed and to improve outcomes in this setting.(8) Better 
information through improved coding can lead to more appropriate diagnostic testing 
and avoidance of allergens so that patients benefit from new advances in, for example, 
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immunotherapy and biologic agents.(7, 21) The advent of this personalized medicine 
approach requires careful documentation of specific details about the patient’s 
disease experience and test results. However, we have shown that in practice in 
Scotland, only 10% of the 352 available codes were used 95% of the times (Table 1). 
Thus, a list of the 10% most frequently used codes will be adequate for coding most 
allergic diseases in primary care.  In fact 80% of code usage was for 3% of the codes, 
which is much more extreme than Pareto’s 80-20 rule.(22) There were 73 codes which 
were never used, of which 42 were low-level codes.  
Our analysis has shown that the currently available Read allergy codes can be divided 
into those that are highly-used, moderately-used and never-used. While it would be 
unwise to abandon the “never-used” codes, since rare cases do occur, it might be 
prudent to not spend much time on transferring these codes to SNOMED-CT. It 
certainly would be useful for accurate coding if the highly used/non-specific codes are 
available with more details in SNOMED-CT. It is important for allergy specialists to 
identify the most useful codes in primary care and highlight these, so that selection of 
codes during a busy consultation is made easy and the list of allergy codes remains 
manageable and better utilized. This finding echoes the survey response from 52% of 
612 members in 144 countries who were in favour of having up to 30 diagnostic 
categories and 36% for up to 100 categories in a classification system for allergic 
diseases.(2)  
Appropriate usage of codes for recording allergic diseases will prevent 
misclassification of patients and inaccuracies, thereby leading to better data quality for 
research. Research is needed to understand why some codes were never or rarely 
used. It is not known whether the code descriptions were difficult to access by busy 
GPs, perhaps from a long drop down list (e.g. ‘allergy to strawberries’) or whether 
perhaps GPs prefer to record such encounters using free-text,(23) as reported in a 
recent study.(24) This may also reflect the fact that, while asthma patients are mainly 
managed in primary care in the UK, patients with some other allergies (for example, 
food allergy and anaphylaxis) are more likely to be referred to hospitals for ongoing 
care. Hence terms for the former are more likely to be recorded in GP records.  
Some of these codes (e.g. ‘RAST tests’, ‘mushroom workers lung’) may not be needed and can be 
made obsolete. Coding during clinical consultation has been identified as a barrier by European 
GPs.(25) Unfamiliarity with the available codes could also be an issue, so that much of the 
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consultation is not coded, but is recorded in free-text or narrative. Also sometimes GPs find free-
texts and narratives more useful than numeric or alpha-numeric codes, as writing in their own words 
may help GPs to better understand their notes and hence patients.(26)  Browsing for allergy codes in 
a GP software system can be made easier by listing the 36 most frequently used allergy codes we 
identified, with the other codes listed under ‘other’. To encourage structured data entry and reduce 
free texts, more efficient interfaces which make codes easily searchable during busy consultations 
could be implemented.(17) The remaining codes can be arranged in a logical structure, for example 
by disease area, type of code or causal allergen and then alphabetically. When lower-level codes are 
available, but a GP chooses a high-level or middle-level code, it would be useful if the software offers 
an option for all low-level codes, prompting “Did you mean...” and “maximum number of middle-
level and low-level codes are X”, as opposed to how they are laid out currently (Figure 1). It would 
also be useful to offer GPs an appropriate choice of allergens when they code an allergic disease, by 
prompting “due to…” and “maximum number of allergens that can be offered are Y”. This can be 
achieved using post-coordination in SNOMED-CT,(27) which has been found to be better suited as a 
terminology to describe an allergic reaction.(28) While a more detailed terminology is an essential 
pre-requisite to improving allergy coding, it is unlikely to be sufficient. This is because coding is a 
complex behaviour that is influenced, amongst other things, by personal preference, local context 
and incentives. In addition to the welcome detail in SNOMED-CT’s structure and its user friendly 
browser, there needs to be training, incentives and feedback to clinicians to promote more accurate 
coding. An area of further research could be how post-coordination helps, to characterise patients 
with allergies. Another possible way forward is for greater use of coding clerks as occurs in UK 
hospitals and is being considered in US primary care practices.(29) 
 
Current research suggests that asthma is an umbrella term for many diseases;(30) 
there is furthermore the opportunity for more detailed phenotypic characterisation of 
other allergic diseases.(20) Some progress has been made to address these issues by 
using cross-linking terms in ICD-11,(31, 32) and post-coordination in SNOMED-CT,(28) 
which have the potential to improve the phenotypic characterisation of asthma,  
allergies and hyper-sensitivities. 
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Conclusions  
We believe that our findings show that simply moving to the more comprehensive 
multi-axial SNOMED-CT coding system is unlikely to improve the GP coding of allergy if 
the current coding behaviour of GPs persist. Rather, improving the range and depth of 
codes used by clinicians to achieve the envisaged “rich phenotype” will require several 
additional activities. Given the very substantial investments being made in exploiting 
routine data for research in the UK through the Farr Institute, MRC Medical 
Bioinformatics Centres etc. and elsewhere, there is a need to take active steps to 
ensure that patient data are of high quality, which includes the level of detail.(33)  The 
imminent move to SNOMED-CT represents an important opportunity to work with the 
relevant health informatics and clinical communities to move this work forward. Our 
detailed analysis of allergy codes and their usage provides an evidence base to guide 
the future development and adoption of SNOMED-CT, with the allergy profession 
leading the way. 
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Table 1: List of the most frequently used 36 (10%) of the 352 Read allergy codes in primary care in 
Scotland during 2003-04 to 2009-10, by percentage usage out of total of 2,311,843 usages, and 
annual rate of use of the code per consultation, sorted by usage rate of the code 
Greyed cells are the codes used for the Quality Outcomes Framework 
Disease Area Read code description Read 
code 
Percentage use of 
this code out of 
total usage of 
Use of this code per 
consultation seen 
for this code
Asthma                       Inhaler technique - good                                                                   663H. 22.0% 1.1
Asthma                       Asthma not disturbing sleep                                                             663O. 16.1% 1.1
Asthma                       Asthma not limiting activities                                                           663Q. 15.5% 1.1 
Asthma                       Asthma                                                                                                 H33.. 4.7% 1.4
Asthma                       Asthma limiting activities                                                                  663P. 4.1% 1.1
Asthma                       Asthma disturbing sleep                                                                    663N. 3.6% 1.1
Asthma                       Asthma monitoring                                                                            663.. 3.6% 1.4
Asthma                       Asthma NOS                                                                                         H33zz 3.2% 1.2
Asthma                       Inhaler technique observed                                                              6637. 2.4% 1.2
Asthma                       Asthma management plan given                                                     663U. 1.9% 1.1
Asthma                       Asthma unspecified                                                                            H33z. 1.6% 1.4
Asthma                       Spacer device in use                                                                           663I. 1.5% 1.1
Asthma                       Asthma treatment compliance satisfactory                                   663n. 1.0% 1.1
Asthma                       Acute exacerbation of asthma                                                         H333. 0.9% 1.3
Asthma                       Inhaler technique shown                                                                  6636. 0.5% 1.1
Asthma                       Asthma trigger                                                                                    178.. 0.5% 1.0
Asthma                       Bronchodilators used more than once daily                                  663L. 0.3% 1.1
Asthma                       Resp. treatment changed                                                                  663B. 0.3% 1.1
Asthma                       Follow-up resp. assessment                                                             6632. 0.2% 1.2
Asthma                       Bronchodilators used a maximum of once daily                           663M. 0.2% 1.1
Asthma                       Asthma treatment compliance unsatisfactory                              663p. 0.2% 1.0
Conjunctivitis Other chronic allergic conjunctivitis                                             F4C14 0.2% 1.1 
Drug allergy Drug hypersensitivity NOS SN52. 1.1% 1.2
Drug allergy [V]Personal history of drug allergy ZV14. 0.9% 1.2
Drug allergy [V]Personal history of penicillin allergy ZV140 0.7% 1.0 
Drug allergy H/O: drug allergy 14L.. 0.7% 1.2
Drug allergy H/O: penicillin allergy 14L1. 0.4% 1.0
Eczema Eczema NOS                                                                                          M12z1 2.6% 1.2 
Eczema Atopic dermatitis/eczema  M111. 0.7% 1.1
Eczema Dermatitis NOS                                                                                    M12z0 0.6% 1.2
Other Allergy SN53. 0.4% 1.1 
Rhinitis                        Allergic rhinitis due to unspecified allergen                                   H172. 0.9% 1.1
Rhinitis                        Allergic rhinitis                                                                                    H17.. 0.6% 1.1
Rhinitis                        Allergic rhinitis due to pollens                                                          H170. 0.4% 1.0 
Rhinitis                        Allergic rhinitis due to other allergens                                            H171. 0.3% 1.2
Urticaria                     Urticaria                                                                                                M28.. 0.6% 1.2
Source: Primary Care Clinical Informatics Unit Research (PCCIU-R), Scotland 
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Table 2: List of the 73 Read allergy codes which were never used in primary care in Scotland during 
2003-04 to 2009-10, sorted by disease area 
Disease Area Read code description Read code 
Anaphylaxis Anaphylactoid glomerulonephritis K0323 
Anaphylaxis Anaphylactoid reaction due to haemodialysis SP0G. 
Anaphylaxis Anaphylactic shock due to serum SP34. 
Angioedema Acquired C1 esterase inhibitor deficiency SN510 
Angioedema Hereditary C1 esterase inhibitor deficiency SN511 
Asthma                      Asthma trigger - pollen                                                                                                      1781. 
Asthma                      Asthma trigger - tobacco smoke                                                                                      1782. 
Asthma                      Asthma trigger - warm air                                                                                                 1783. 
Asthma                      Asthma trigger - emotion                                                                                                 1784. 
Asthma                      Asthma trigger - damp                                                                                                       1785. 
Asthma                      Asthma trigger - animals                                                                                                   1786. 
Asthma                      Asthma trigger - seasonal                                                                                                 1787. 
Asthma                      Asthma trigger - cold air                                                                                                   1788. 
Asthma                      Asthma trigger - respiratory infection                                                                            1789. 
Asthma                      Asthma trigger - airborne dust                                                                                         178A. 
Asthma                      Asthma trigger - exercise                                                                                                  178B. 
Asthma                      Asthma severely restricts exercise                                                                                  6630. 
Asthma                      Respiratory disease treatment started                                                                          663C. 
Asthma                      Respiratory disease  stopped                                                                                           663D. 
Asthma                      Using inhaled steroids - low dose                                                                                    663g4 
Asthma                      Non-invasive ventilation therapy review                                                                        663i.
Asthma                      Declined to perform inhaler technique                                                                         663o. 
Asthma                      Asthma limits activities 1 to 2 times per month                                                           663P0 
Asthma                      Asthma limits activities 1 to 2 times per week                                                              663P1 
Asthma                      Asthma limits activities most days                                                                                  663P2 
Asthma                      Bronchodilator used infrequently                                                                                    663Z0 
Asthma                      Bronchodilator not used in last month                                                                           663Z1 
Asthma                      Chronic asthma with fixed airflow obstruction H335. 
Asthma                      Sequoiosis (red-cedar asthma) H35y6 
Drug allergy H/O: selective oestrogen receptor modulator allergy 14LV.
Eczema Asteatotic eczema M11A. 
Food allergy              Mushroom allergy                                                                                                              SN588 
Food allergy              Allergy to strawberries                                                                                                      SN589 
Food allergy              Allergy to soya                                                                                                                    SN58A 
Other Casoni skin test 3358. 
Other Allergy test - not skin 336%
Other Further RAST tests 43l% 
Other RAST test 43Q% 
Other Supplementary RAST tests 43t%
Other Other RAST test 43Y% 
Other Allergic disease follow-up assessment 66G2. 
Other Closed special patch testing of skin 7P153 
Other Patch testing of skin with patient's own products 7P155 
Other Other specified diagnostic application tests on skin 7P15y 
Other Diagnostic application tests on skin NOS 7P15z 
Other Allergy diagnostic series 1 skin prick testing kit c951. 
Other Allergy diagnostic series 2 skin prick testing kit c952.
Other Bagassosis H351. 
Other Bird-fancier's lung NOS H352z 
Other Suberosis ( cork-handlers' lung ) H353. 
Other Malt workers' lung H354. 
Other Mushroom workers' lung H355. 
Other Maple bark strippers' lung H356. 
Other Fish-meal workers' lung H35y2 
Other Furriers' lung H35y3 
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Disease Area Read code description Read code 
Other Grain-handlers' disease H35y4 
Other Pituitary snuff-takers' disease H35y5 
Other Air-conditioner and humidifier lung H35y8 
Other Allergic parotitis J0720 
Other Allergic enterocolitis J4322 
Other Allergic gastroenteritis NOS J432z
Other Allergic arthritis of unspecified site N0620 
Other Allergic arthritis of the upper arm N0622 
Other Allergic arthritis of the forearm N0623 
Other Allergic arthritis of the pelvic region and thigh N0625 
Other Allergic arthritis of the lower leg N0626 
Other Allergic arthritis of other specified site N0628 
Rhinitis                       Other seasonal allergic rhinitis Hyu20 
Rhinitis                       Other allergic rhinitis Hyu21 
Urticaria                     Vibratory urticaria                                                                                                             M284. 
Urticaria                     Urticaria geographica                                                                                                        M28y0 
Urticaria                     Menstrual urticaria                                                                                                             M28y1 
Urticaria                     Urticaria persistans                                                                                                            M28y2 
Source: Primary Care Clinical Informatics Unit Research (PCCIU-R), Scotland 
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